US 8334259
Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative
granted A61KA61K38/10A61K38/16
Quick answer
US patent 8334259 (Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative) held by The Board of Regents of the University of Texas System expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/10, A61K38/16, A61K38/18, A61K38/4833